Tim McCarthy, Chairman of ImmuPharma #IMM - 17th May 2017
Tim McCarthy, Chairman of ImmuPharma #IMM gives an update, on its lead compound, Lupuzor™ in its pivotal Phase III study.
ImmuPharma is a pharmaceutical development company listed since 2006 on AIM of the London Stock Exchange (LSE:IMM), focusing on developing novel medicines with high sales potential in specialist markets with serious unmet need. ImmuPharma is led by a commercially focused Board and management team with extensive experience.
Vox Markets is a stock market resource platform, that aggregates investor relations information.
It specialises in the latest stock market news, company information, live prices, interviews and views from Asset Managers, Stock Brokers, Hedge Fund Managers, Private Investors, Independent Financial Advisors and Investment Managers.